APA (7th ed.) Citation

Y, C., P, Z., F, W., H, Z., H, S., A, M., . . . S, C. (2025). Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers. Science translational medicine, 17(801), eadk7786. https://doi.org/10.1126/scitranslmed.adk7786

Chicago Style (17th ed.) Citation

Y, Cai, et al. "Inhibition of NR2F2 Restores Hormone Therapy Response to Endocrine Refractory Breast Cancers." Science Translational Medicine 17, no. 801 (2025): eadk7786. https://doi.org/10.1126/scitranslmed.adk7786.

MLA (9th ed.) Citation

Y, Cai, et al. "Inhibition of NR2F2 Restores Hormone Therapy Response to Endocrine Refractory Breast Cancers." Science Translational Medicine, vol. 17, no. 801, 2025, p. eadk7786, https://doi.org/10.1126/scitranslmed.adk7786.